Epidemiology, Genetics, and Risk Factors in Androgenetic Alopecia
May 2026
in “
Zenodo (CERN European Organization for Nuclear Research)
”
androgenetic alopecia AGA dihydrotestosterone DHT 5-alpha reductase minoxidil finasteride platelet-rich plasma PRP low-level laser therapy hair transplants anagen phase telogen phase follicular sensitivity androgen hormones inflammation oxidative stress microvascular changes Propecia Rogaine Botox hair transplant surgery laser hair therapy
Preprint — not peer reviewed. This was posted to a preprint server or data repository. It has not been through a journal's review process, and its findings may change or not hold up.
Studysummary This review explores the complex pathophysiology of androgenetic alopecia, highlighting genetic factors, androgen metabolism, and emerging therapies such as platelet-rich plasma and low-level laser therapy, but notes that no ultimate cure exists and treatments focus on slowing progression and promoting hair growth.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
